Booster Vaccine Enhances BCG Immunity Against Tuberculosis
Author Information
Author(s): Dey Bappaditya, Jain Ruchi, Gupta Umesh D., Katoch V. M., Ramanathan V. D., Tyagi Anil K.
Primary Institution: University of Delhi South Campus
Hypothesis
Can a DNA vaccine expressing a latency-associated antigen improve the immunity provided by the BCG vaccine against tuberculosis?
Conclusion
The study shows that the DNA vaccine significantly boosts the immunity provided by BCG, leading to better protection against tuberculosis.
Supporting Evidence
- The BCG prime-DNA boost regimen showed a significant reduction in bacillary load in guinea pigs.
- Enhanced protection was observed in mice vaccinated with the B/D regimen compared to BCG alone.
- Vaccination with the B/D regimen resulted in a higher frequency of multifunctional CD4 T cells.
Takeaway
Researchers found that a new vaccine can make the existing BCG vaccine work better against tuberculosis, helping the body fight the disease more effectively.
Methodology
The study involved guinea pigs and mice, evaluating the protective efficacy of a DNA vaccine following BCG vaccination.
Limitations
The study's findings in mice may not directly translate to guinea pigs due to species-specific immune responses.
Participant Demographics
Guinea pigs and mice were used in the experiments.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website